RalGAP complexes control secretion and primary cilia in pancreatic disease.

Area of Science:

• Molecular biology
• Cancer research
• Cell signaling

Background:

• κB-Ras/RalGAP complexes regulate Ral GTPase activity in EGFR/Ras signaling.
• RalGAP expression is reduced in pancreatic cancer, but its in vivo role is unclear.

Purpose of the Study:

• To investigate the role of RalGAP and Ral GTPases in pancreatic tumor development in vivo.
• To elucidate the mechanisms by which RalGAP deficiency impacts acinar cell function and regeneration.

Main Methods:

• Analysis of pancreatic RalGAPβ deficiency in vivo.
• Investigation of secretory pathway and exocytosis in acinar cells.
• Assessment of primary cilium assembly and acinar regeneration.
• Combination studies with oncogenic KRAS^G12D mutation.

Main Results:

• Pancreatic RalGAPβ deficiency alone induces inflammation and neoplasia.
• Deficiency disrupts secretory pathways, polarized exocytosis, and primary cilium assembly.
• RalGAPβ deficiency accelerates tumor development and reduces survival in combination with KRAS^G12D.

Conclusions:

• RalGAP complexes maintain spatial control of Ral activity and acinar cell identity.
• RalGAP/Ral signaling is crucial for preventing pancreatic cancer development.
• κB-Ras proteins are specifically required for primary cilium formation, not all RalGAP functions.